Open AccessThe role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial
Author(s) -
Carlo Cagini,
Marco Mariniello,
Marco Messina,
Alessio Muzi,
Chiara Balducci,
A Moretti,
Lucia Levorato,
Antonella Mencacci
Publication year - 2020
Publication title -
international ophtalmology/international ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.716
H-Index - 45
eISSN - 1573-2630
pISSN - 0165-5701
DOI - 10.1007/s10792-020-01503-4
Subject(s) - medicine , dexamethasone , chemosis , tobramycin , keratitis , eye drop , randomized controlled trial , clinical trial , surgery , ophthalmology , antibiotics , gentamicin , microbiology and biotechnology , biology
To determine whether topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops reduces clinical signs and infectious viral titers of presumed viral conjunctivitis more than tobramycin/dexamethasone eye drops alone.